Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 4
1965 4
1966 3
1967 11
1968 12
1969 23
1970 19
1971 23
1972 18
1973 22
1974 28
1975 39
1976 20
1977 25
1978 26
1979 46
1980 33
1981 40
1982 62
1983 75
1984 97
1985 79
1986 90
1987 95
1988 124
1989 118
1990 133
1991 130
1992 152
1993 125
1994 164
1995 168
1996 109
1997 130
1998 123
1999 153
2000 145
2001 143
2002 149
2003 170
2004 134
2005 154
2006 192
2007 140
2008 168
2009 129
2010 124
2011 143
2012 178
2013 170
2014 203
2015 174
2016 192
2017 205
2018 241
2019 264
2020 255
2021 266
2022 281
2023 272
2024 113

Text availability

Article attribute

Article type

Publication date

Search Results

6,746 results

Results by year

Filters applied: . Clear all
Page 1
Classifying cephalosporins: from generation to cross-reactivity.
Fernandez J, Jimenez-Rodriguez TW, Blanca-Lopez N. Fernandez J, et al. Curr Opin Allergy Clin Immunol. 2021 Aug 1;21(4):346-354. doi: 10.1097/ACI.0000000000000755. Curr Opin Allergy Clin Immunol. 2021. PMID: 34074874 Review.
PURPOSE OF REVIEW: To review the most recent literature studying the classifications, immunochemistry, and crossreactivity of allergy reactions to cephalosporins. RECENT FINDINGS: Over the last five years, research interest has focused on three areas related …
PURPOSE OF REVIEW: To review the most recent literature studying the classifications, immunochemistry, and crossreactivity of …
Cefepime-induced neurotoxicity: a systematic review.
Payne LE, Gagnon DJ, Riker RR, Seder DB, Glisic EK, Morris JG, Fraser GL. Payne LE, et al. Crit Care. 2017 Nov 14;21(1):276. doi: 10.1186/s13054-017-1856-1. Crit Care. 2017. PMID: 29137682 Free PMC article. Review.
Two reviewers independently assessed identified articles for eligibility and used the Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) for data reporting. ...
Two reviewers independently assessed identified articles for eligibility and used the Preferred Reporting Items for Systematic review …
Pharmacokinetics of cephalosporins in the neonate: a review.
Pacifici GM. Pacifici GM. Clinics (Sao Paulo). 2011;66(7):1267-74. doi: 10.1590/s1807-59322011000700024. Clinics (Sao Paulo). 2011. PMID: 21876985 Free PMC article. Review.
The aim of this work was to review the published data on the pharmacokinetics of cephalosporins in neonates to provide a critical analysis of the literature as a useful tool for physicians. ...The maturation of the kidney governs the pharmacokinetics of cephalosp …
The aim of this work was to review the published data on the pharmacokinetics of cephalosporins in neonates to provide a criti …
Third-generation cephalosporins: a review.
Cunha BA. Cunha BA. Clin Ther. 1992 Sep-Oct;14(5):616-52; discussion 615. Clin Ther. 1992. PMID: 1468084 Review.
Choice of drug should be based on antimicrobial spectrum and other factors such as lack of resistance development and cost considerations. This review focuses on the distinguishing features of the parenteral third-generation cephalosporins. Such differences suggest …
Choice of drug should be based on antimicrobial spectrum and other factors such as lack of resistance development and cost considerations. T …
Cephalosporin Allergy: Current Understanding and Future Challenges.
Khan DA, Banerji A, Bernstein JA, Bilgicer B, Blumenthal K, Castells M, Ein D, Lang DM, Phillips E. Khan DA, et al. J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2105-2114. doi: 10.1016/j.jaip.2019.06.001. J Allergy Clin Immunol Pract. 2019. PMID: 31495420 Free PMC article. Review.
Patients allergic to cephalosporins tend to tolerate cephalosporins with disparate R1 side chains but may react to other beta-lactams with common R1 side chains. Skin testing for cephalosporins has not been well validated but appears to have a good negative p …
Patients allergic to cephalosporins tend to tolerate cephalosporins with disparate R1 side chains but may react to other beta- …
The oral cephalosporins--a review.
Morrow JD. Morrow JD. Am J Med Sci. 1992 Jan;303(1):35-9. doi: 10.1097/00000441-199201000-00008. Am J Med Sci. 1992. PMID: 1728874 Review.
There are currently six cephalosporins available in the United States for oral use. These agents possess a wide spectrum of activity, are relatively safe to use, and are effective for certain infections involving the respiratory tract, skin, and urinary tract. Nonetheless, …
There are currently six cephalosporins available in the United States for oral use. These agents possess a wide spectrum of activity, …
New Perspectives on Antimicrobial Agents: Cefiderocol.
McCreary EK, Heil EL, Tamma PD. McCreary EK, et al. Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0217120. doi: 10.1128/AAC.02171-20. Epub 2021 Jul 16. Antimicrob Agents Chemother. 2021. PMID: 34031052 Free PMC article. Review.
No available agent comes close to the broad range of activity afforded by cefiderocol, a novel siderophore-cephalosporin conjugate. The novelty of and need for cefiderocol are clear, but available clinical data are conflicting, leaving infectious diseases specialists puzzl …
No available agent comes close to the broad range of activity afforded by cefiderocol, a novel siderophore-cephalosporin conjugate. T …
[New cephalosporins].
Olarte-Luis T, Cáceres-Galíndez D, Cortés JA. Olarte-Luis T, et al. Rev Chilena Infectol. 2018;35(5):465-475. doi: 10.4067/s0716-10182018000500465. Rev Chilena Infectol. 2018. PMID: 30724992 Free article. Review. Spanish.
Bacterial resistance has increased in Latin America and the world, making research and creation of new antimicrobials capable of eradicating resistant microorganisms essential. A review of new cephalosporins and their combinations with a beta-lactamase inhibitor was …
Bacterial resistance has increased in Latin America and the world, making research and creation of new antimicrobials capable of eradicating …
Newer cephalosporins and cephamycins--a review.
Norrby R. Norrby R. Scand J Infect Dis Suppl. 1978;(13):83-7. Scand J Infect Dis Suppl. 1978. PMID: 356183 Review.
Since the introduction of cephalothin and cephaloridine as the first parenteral cephalosporins and cephalexin as the first member of the group which is absorbed from the gastrointestinal tract, several new cephalosporin derivatives have been developed. ...Cefoxitin …
Since the introduction of cephalothin and cephaloridine as the first parenteral cephalosporins and cephalexin as the first member of …
Immunologic cross-reactivity between penicillins and cephalosporins: a review.
Petz LD. Petz LD. J Infect Dis. 1978 May;137 Suppl:S74-S79. doi: 10.1093/infdis/137.supplement.s74. J Infect Dis. 1978. PMID: 77300 Review.
Various degrees of cross-reactivity of antibodies produced in response to administration of these drugs have been demonstrated both with test systems that measure IgG and IgM antibodies and with those that measure IgE antibodies. The clinical significance of immune responses to …
Various degrees of cross-reactivity of antibodies produced in response to administration of these drugs have been demonstrated both with tes …
6,746 results